These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21978025)

  • 21. Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease.
    Munakata M; Sakuraba J; Tayama J; Furuta T; Yusa A; Nunokawa T; Yoshinaga K; Toyota T
    Hypertens Res; 2005 Jan; 28(1):9-14. PubMed ID: 15969249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.
    Hernández-delRey R; Armario P; Martin-Baranera M; Sánchez P; Cárdenas G; Pardell H
    Blood Press Monit; 1998; 3(6):331-7. PubMed ID: 10212374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between grade II hypertensive retinopathy and coronary artery disease in treated essential hypertensives.
    Kim GH; Youn HJ; Kang S; Choi YS; Moon JI
    Clin Exp Hypertens; 2010; 32(7):469-73. PubMed ID: 21029012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure load, vascular permeability and target organ damage in primary hypertension.
    Falqui V; Viazzi F; Leoncini G; Ratto E; Parodi A; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Nephrol; 2007; 20 Suppl 12():S63-7. PubMed ID: 18050146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Status of end organs in newly detected rural essential hypertensives: a study from southern India.
    Meenakshisundaram R; Babuvinish D; Grootveld M; Rajendiran C; Thirumalaikolundusubramanian P
    Clin Exp Hypertens; 2012; 34(3):201-8. PubMed ID: 22150025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations between sarcopenia and hypertensive target organ damage in a Turkish cohort.
    Doğan MH; Karadag B; Ozyigit T; Kayaoglu S; Ozturk AO; Altuntas Y
    Acta Clin Belg; 2012; 67(5):328-32. PubMed ID: 23189539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial clustering of hypertensive target organ damage in the community.
    Niiranen TJ; Lin H; Larson MG; Vasan RS
    J Hypertens; 2018 May; 36(5):1086-1093. PubMed ID: 29369144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cumulative Effects of Several Target Organ Damages in Risk Assessment in Hypertension.
    Harbaoui B; Courand PY; Defforges A; Khettab F; Milon H; Girerd N; Lantelme P
    Am J Hypertens; 2016 Feb; 29(2):234-44. PubMed ID: 26112867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients.
    Kabedi NN; Mwanza JC; Lepira FB; Kayembe TK; Kayembe DL
    Cardiovasc J Afr; 2014; 25(5):228-32. PubMed ID: 25629539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender, socio-economic variables and target organ damage in new-diagnosed hypertensive patients.
    de Tuero GC; Barcelò MA; Saez M
    Blood Press; 2009; 18(4):213-22. PubMed ID: 19591005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the association of retinopathy with metabolic syndrome, ambulatory blood pressure and cardiac remodeling in hypertensive individuals.
    Katsi V; Souretis G; Alexopoulos N; Vlachopoulos C; Dagalaki I; Sideris S; Tousoulis D; Stefanadis C; Kallikazaros I
    Int J Cardiol; 2013 Jul; 166(3):764-6. PubMed ID: 23073271
    [No Abstract]   [Full Text] [Related]  

  • 33. Microalbuminuria and hypertensive retinopathy among newly diagnosed nondiabetic hypertensive adult Nigerians.
    Busari OA; Opadijo OG; Omotoso AB
    Niger J Clin Pract; 2011; 14(4):436-9. PubMed ID: 22248945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension.
    Kolman SA; van Sijl AM; van der Sluijs FA; van de Ree MA
    J Hum Hypertens; 2017 Feb; 31(2):121-125. PubMed ID: 27465980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertensive target organ damage in Ghanaian civil servants with hypertension.
    Addo J; Smeeth L; Leon DA
    PLoS One; 2009 Aug; 4(8):e6672. PubMed ID: 19701488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are there height-dependent differences in subclinical vascular disease in hypertensive patients?
    Ferriol C; Tremols S; Jimenez C; Tura A; Sanmartín M; Pagès N; Rodríguez-Poncelas A; Paz-Bermejo M; Saez M; Coll-de-Tuero G
    J Clin Hypertens (Greenwich); 2014 Jan; 16(1):70-6. PubMed ID: 24188542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and clinical spectrum of hypertensive retinopathy among hypertension clinic patients at Queen Elizabeth Central Hospital in Malawi.
    Kayange PC; Schwering MS; Manda CS; Singini I; Moyo VVP; Kumwenda J
    Malawi Med J; 2018 Sep; 30(3):180-183. PubMed ID: 30627353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing risk stratification in hypertensive subjects: how far should we go in routine screening for target organ damage?
    Chalmers J;
    J Hypertens; 2002 Jul; 20(7):1255-7. PubMed ID: 12131513
    [No Abstract]   [Full Text] [Related]  

  • 39. End organ damage in hypertension.
    Schmieder RE
    Dtsch Arztebl Int; 2010 Dec; 107(49):866-73. PubMed ID: 21191547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension in adolescents and young adults referred to a tertiary hypertension clinic in Cape Town, South Africa.
    Jones ESW; Esack I; Mangena P; Rayner BL
    Medicine (Baltimore); 2020 Nov; 99(48):e23137. PubMed ID: 33235075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.